Anavex Life Sciences Corp (AVXL)

[Investor2014]

The (maybe valid) assumption is that the data and results we are party to are indicative of a drug that works.

A decade of positive signals is not fake news.

I remain cautious on that as the P2 AD trial was very small and open label. The P2b/3 was too small and short, got rejected by CHMP and did not overall confirm the analysis results of the P2 trial.

Meanwhile, Rett also failed quite spectacularly.